House Appropriators Push FDA To Issue Generic Drug Labeling Rule That Mirrors Industry Alternative

House appropriators are pressing FDA to scrap its controversial generic drug labeling plan and instead quickly issue a final rule that closely tracks an industry-backed alternative, laying out their concerns in FDA appropriations report language released Tuesday (June 23). The move puts the appropriators at odds with a group of 47 House and Senate Democrats who wrote to FDA in late April calling for the rule to be finalized as is. Appropriators say FDA's proposal that generic drug makers update...